Blood Journal/X
Jun 7, 2025, 10:28
IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
The Blood Journal featured a post highlighting the published article on X:
“Hallmarks of IL-10 deficiency predict R-CHOP response but reflect poor antitumor immunity in preclinical models and patients with DLBCL.”
Title: IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy
Authors: Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Marién Pascual, Enrique Goñi, Iñigo Clemente-Larramendi, Sandra Morales-Sánchez, María A. Burrell, Oscar Blanco, Adrián Arnaiz-Leché, Blanca S. Berrozpe, Maria Amann, Christian Klein, Pablo Umaña, Miguel Canales, José Ángel Martínez-Climent, Juan J. Lasarte, Pablo Sarobe, Francisco J. Novo, Sergio Roa
Find more posts on Hemostasis Today.
-
Nov 21, 2025, 14:26Haroun Gajraj: Stop Before You Inject Spider Veins Around the Ankle
-
Nov 21, 2025, 14:26Michael Makris: New UK Guideline on Acquired Coagulation Factor Inhibitors
-
Nov 21, 2025, 14:24William Wallace: Magnesium – Role in Blood Pressure Regulation
-
Nov 21, 2025, 14:23Mohamed Magdy Badr: How Do Acute Wounds Turn Into Chronic Wounds?
-
Nov 21, 2025, 14:22Ron DePinho: A Transformative Insight into Lupus – and the Virus Nearly All of Us Carry
-
Nov 21, 2025, 14:18Michael Bartholomew: Fix Your Mitochondria, Fix Almost Everything
-
Nov 21, 2025, 14:16Gianluca Franceschini on Fostering Innovation in Breast Cancer Care
-
Nov 21, 2025, 14:13Jon Faldasz: Ondansetron May Have Cardiotoxicity Risk Among 5-HT3RAs Due to High Concentration in Cardiac Tissues
-
Nov 21, 2025, 14:10Hortense Triniac Shares PhD Research: How Cortical Neurons Process and Activate tPA